Melola Discovery

← Melola Discovery

Open access Journal SINTA 1

The role of N-terminal pro-brain natriuretic peptide as an early alert of pulmonary hypertension in chronic lung disease

Heart Science Journal · Vol. 7 No. 2 (2026) · pp. 81–85

DOI
10.21776/ub.hsj.2026.007.02.12
ISSN
2721-9984, 2721-9976
Published
2026-04-26
Publisher
Universitas Brawijaya
Language
en
License
creativecommons.org/licenses/by/4.0

Abstract

BACKGROUND: One of the primary causes of illness and dying in worldwide was chronic lung disease (CLD). Pulmonary hypertension (PH) was among the most popular issues linked to CLD, often remaining undiagnosed in the early stages. N-terminal pro-brain natriuretic peptide (NT-proBNP) and electrocardiographic abnormalities could be early alert of pulmonary hypertension. OBJECTIVES: This study aims to ascertain the role of NT-proBNP as early markers of pulmonary hypertension in CLD. METHOD: This study used a cross-sectional design in 2024, and there where 35 patients with CLD were analyzed. A group of normal individuals without cardiac and pulmonary abnormalities was used as a control group. Data on patient characteristics, symptoms, typical electrocardiography (ECG) results of pulmonary hypertension, as well as serum NT-proBNP levels was measured at baseline before any intervention. RESULTS: Most patients were male (85.7%) and aged ≥60 years (51.4%), and Chronic Obstructive Pulmonary Disease (COPD) is the most popular CLD (65.7%). Prolonged QT (20%) was the most prevalent ECG abnormality, followed by right axis deviation (14.7%) and Right Bundle Branch Block (11.42%). The COPD group had the most elevated NT-proBNP levels (mean 90.22 pg/mL), then the Pulmonary Tuberculosis Lung Disease group at 74.34 pg/mL, and in normal individuals (57.89 pg/mL). The NTproBNP levels differed significantly amongst the groups (p = 0.0215). CONCLUSION: COPD, which is the most CLD, showed the highest prevalence of early pulmonary hypertension, characterized by increased NT-proBNP and QT prolongation. In CLD, NT-proBNP could be utilized as an indicator of the initial identification of pulmonary hypertension.

Keywords

Collaboration network of the authors

19 authors · 43 co-authorship links · 20 across different organisations

Hover or tap a name to highlight its co-authors. Double-click to open the author's page.

  • Universitas Syiah Kuala
  • Politeknik Kampar
  • University of Palangka Raya
  • Hasanuddin University
  • Sebelas Maret University
  • Universitas Jember
  • IPB University
  • Other organisations
  • Affiliation unknown
  • Different organisations
  • Same organisation
  • Affiliation unknown
  • Thicker line = more joint articles · bigger circle = more articles
Show as table
Co-authorOrganisationJoint articles
Andri Nofiar AmPoliteknik Kampar1
Antoni PribadiPoliteknik Kampar1
Wahiduddin WahiduddinHasanuddin University1
Eko MulyadiAffiliation unknown1
Yuliana Mahdiyah Da’at ArinaUniversitas Jember1
Revi Gama Hatta NovikaSebelas Maret University1
Natalia Sri MartaniUniversity of Palangka Raya1
Nawan NawanUniversity of Palangka Raya1
Riyan ArisandiUniversitas Syiah Kuala1
Iskandar ZakariaUniversitas Syiah Kuala1
Siti Sarah HajarIPB University1
Aulia Rahma AsrilUniversitas Syiah Kuala1
Dewi Behtri YanifitriUniversitas Syiah Kuala1
Diennisa Shafira MursalinUniversity of Indonesia1

Affiliations come from OpenAlex; journal OAI-PMH metadata carries none. Authors without an OpenAlex ID are matched by name, which can merge or split people.

Metadata source: OAI-PMH (metadata jurnal) https://heartscience.ub.ac.id/index.php/heartscience/oai, first harvested 8 Nov 2026, last seen 16 Nov 2026.
Original metadata (oai_dc)
<oai_dc:dc xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/  http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
	<dc:title xml:lang="en">The role of N-terminal pro-brain natriuretic peptide as an early alert of pulmonary hypertension in chronic lung disease</dc:title>
	<dc:creator xml:lang="en">Hulaimi</dc:creator>
	<dc:creator xml:lang="en">Yanti, Budi</dc:creator>
	<dc:creator xml:lang="en">Ridwan, Muhammad</dc:creator>
	<dc:creator xml:lang="en">Arliny, Yunita</dc:creator>
	<dc:creator xml:lang="en">Nurrahmah</dc:creator>
	<dc:subject xml:lang="en">Chronic Lung Disease, Pulmonary Hypertension, NT-proBNP, COPD, Tuberculosis </dc:subject>
	<dc:description xml:lang="en">BACKGROUND: One of the primary causes of illness and dying in worldwide was chronic lung disease (CLD). Pulmonary hypertension (PH) was among the most popular issues linked to CLD, often remaining undiagnosed in the early stages. N-terminal pro-brain natriuretic peptide (NT-proBNP) and electrocardiographic abnormalities could be early alert of pulmonary hypertension.
OBJECTIVES: This study aims to ascertain the role of NT-proBNP as early markers of pulmonary hypertension in CLD.
METHOD: This study used a cross-sectional design in 2024, and there where 35 patients with CLD were analyzed. A group of normal individuals without cardiac and pulmonary abnormalities was used as a control group. Data on patient characteristics, symptoms, typical electrocardiography (ECG) results of pulmonary hypertension, as well as serum NT-proBNP levels was measured at baseline before any intervention.
RESULTS: Most patients were male (85.7%) and aged ≥60 years (51.4%), and Chronic Obstructive Pulmonary Disease (COPD) is the most popular CLD (65.7%). Prolonged QT (20%) was the most prevalent ECG abnormality, followed by right axis deviation (14.7%) and Right Bundle Branch Block (11.42%). The COPD group had the most elevated NT-proBNP levels (mean 90.22 pg/mL), then the Pulmonary Tuberculosis Lung Disease group at 74.34 pg/mL, and in normal individuals (57.89 pg/mL). The NTproBNP levels differed significantly amongst the groups (p = 0.0215).
CONCLUSION: COPD, which is the most CLD, showed the highest prevalence of early pulmonary hypertension, characterized by increased NT-proBNP and QT prolongation. In CLD, NT-proBNP could be utilized as an indicator of the initial identification of pulmonary hypertension. </dc:description>
	<dc:publisher xml:lang="en">Universitas Brawijaya</dc:publisher>
	<dc:date>2026-04-26</dc:date>
	<dc:type>info:eu-repo/semantics/article</dc:type>
	<dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
	<dc:format>application/pdf</dc:format>
	<dc:identifier>https://heartscience.ub.ac.id/index.php/heartscience/article/view/20544</dc:identifier>
	<dc:identifier>10.21776/ub.hsj.2026.007.02.12</dc:identifier>
	<dc:source xml:lang="en">Heart Science Journal; Vol. 7 No. 2 (2026): The Evolving Landscape of Heart Failure; 81-85</dc:source>
	<dc:source>2721-9984</dc:source>
	<dc:source>2721-9976</dc:source>
	<dc:source>10.21776/ub.hsj.2026.007.02</dc:source>
	<dc:language>en</dc:language>
	<dc:relation>https://heartscience.ub.ac.id/index.php/heartscience/article/view/20544/583</dc:relation>
	<dc:rights xml:lang="en">Copyright (c) 2026 Hulaimi, Budi Yanti, Muhammad Ridwan, Yunita Arliny, Nurrahmah</dc:rights>
	<dc:rights xml:lang="en">http://creativecommons.org/licenses/by/4.0</dc:rights>
</oai_dc:dc>